Search PubMed⌕ Search

Biomedical subjects

M Fink

Publications and source records attributed to M Fink.

At least 235 records · Page 13Linked to original sources

Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.

Comparative pharmacokinetic studies with the beta-receptor blocking drugs propranolol, metoprolol, sotalol and atenolol, differing greatly in lipophilicity, and their main route of elimination were performed in light-dark-synchronized rats after equimolar single (6 mumoles/kg) or multiple (6 X 6 mumoles/kg) drug application. Drug concentrations were determined in plasma and various target organs of the drugs, e.g. heart, muscle, lung and brain, after drug application in the light period (L) and dark period (D), respectively. After single drug administration pharmacokinetic parameters of all drugs depended on the L and D conditions. Elimination half-lives in plasma and organs were shorter during D than during L. No L-D-differences were found in initial drug concentrations of the hydrophilic drugs sotalol and atenolol. In contrast, C0-values of the lipophilic propranolol in highly perfused organs (muscle, lung, brain) and of metoprolol in muscle tissue were significantly higher in D than in L. No obvious temporal dependency was found in other pharmacokinetic parameters (AUC, plasma clearance, Vd beta) with the exception in Vd beta of propranolol. Due to the different physico-chemical properties of the compounds inter-drug-differences in pharmacokinetic parameters including drug accumulation into lung and brain tissue were observed. Multiple drug dosing abolished the circadian-phase-dependency in the elimination half-lives of the drugs due to an increase in D. Only for the highly lipophilic propranolol half-lives in highly perfused organs were still shorter in D than in L.(ABSTRACT TRUNCATED AT 250 WORDS)

Adrenergic beta-Antagonists↗

Specular reflector noise: effect and correction for in vivo attenuation estimation.

After reviewing the usual models proposed for the echographic response of soft tissues, we discuss the interaction between the ultrasonic wave and large size obstacles. Structures of this size, specular reflectors, can be found in tissues. The influence of such reflectors on in vivo attenuation measurements is detailed. We point out the importance of the specular echo noise originating from two kinds of reflectors: plane-like and vessel-like reflectors. We present a complete study of their influence on two different algorithms for attenuation estimates: the spectral centroid shift and the narrow band methods. Results are presented on stimulated data, a tissue-mimicking phantom and in vivo muscle data. Different procedures for minimizing the specular echo noise are also discussed.

Humans↗

Noninvasive measurement of central sensory and motor conduction.

Potentials evoked by median and peroneal nerve stimulation were digitally filtered between 300 and 2,500 Hz to measure early latency components and assess sensory cord conduction velocity. Short (R1) and long (R2) latency reflex responses were recorded from contracting thenar and tibialis anterior muscles. R1 is considered a spinal reflex akin to the H-reflex. Clinical evidence suggests that R2 involves a reflex arc with turnaround at the motor cortex. Sensory-motor cord velocity was derived from the latencies of R1 and R2. The method can be used to compare peripheral and central sensory conduction or conduction in central sensory and motor pathways.

Adolescent↗

[Differential diagnosis of hypokalemia--Bartter's syndrome: clinical aspects and therapy].

The case histories of 2 children with the typical characteristics of Bartter's syndrome are reported. The differential diagnosis from other forms of hypokalaemia, as well as pathophysiology and clinical manifestations of this syndrome are presented. The therapeutic effect of indomethacin, an inhibitor of prostaglandin synthesis, is discussed; side effects of this treatment are pointed out.

Adolescent↗

Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.

In 9 newly diagnosed type I diabetic children the residual beta-cell secretory capacity was examined after stimulation with oral glucose load, glucagon and iv glucose plus arginine hydrochloride administration shortly after diagnosis and in the partial remission phase. A significant C-peptide secretion induced by these substances except by iv glucose was found at both investigation times. Whereas beta-cell function did only slightly increase from the initial testing to the measurements in the partial remission, beta-cell sensitivity increased significantly (p less than 0.05). The data suggest that "partial remission" referred to C-peptide secretion starts very early after insulin treatment and that other factors, possibly a decrease of peripheral insulin resistance, are involved in the improved metabolic control in partial remission phase.

Adolescent↗

Meduna and the origins of convulsive therapy.

Convulsive therapy for dementia praecox was first used by the Hungarian neuropsychiatrist Ladislas Meduna in January 1934. On the 50th anniversary the author discusses the introduction of the treatment, the role of a theory of the biological antagonism between epilepsy and schizophrenia, and the contributions of Meduna, Sakel, Cerletti, and Bini. He also describes the changes in usage and methods and the impact of psychotropic drugs on the practice of convulsive therapy.

Antipsychotic Agents↗

[Bone marrow transplantation in adults in acute leukemia, aplastic anemia and paroxysmal nocturnal hemoglobinuria. Results of the Medical Clinic IIi of LMU (Ludwig-Maximilians University) Munich].

Eleven adults have been transplanted for various reasons between July 1979 and July 1982: 2 with aplastic anemia (AA), 1 with paroxysmal nocturnal hemoglobinuria (PNH), 8 with acute leukemia (AL). Four patients suffered from acute lymphocytic leukemia (ALL) and four from acute non-lymphocytic leukemia (ANLL). Two of them were transplanted in relapse, 1 in a partial remission, and 5 in complete remission. All patients were in their late stage of disease. The PNH-patient had an identical twin, 8 patients had an HLA- and MLC compatible sib, 1 an unrelated donor, and 1 was transplanted from his father. Four patients are alive, 2 more than 3 years: 1 with AA and 1 with ALL who was transplanted in relapse. Six patients died of infectious complications (4 of interstitial pneumonia, 1 of a candida sepsis, 1 of acute toxoplasmosis). Patients living more than 3 weeks had a take. Acute graft-versus-host (GvH) disease did not present a major problem. All patients received methotrexate for GvH-prophylaxis, in three instances the marrow was additionally pre-incubated with anti-T-cell globulin.

Acute Disease↗

Familiarization session and placebo control in EEG studies of drug effects.

The need for a familiarization session and for a placebo session for each subject in pharmaco-EEG studies was examined. The data from 18 crossover studies of 22 substances at 33 doses in 112 subjects was used: 371 drug sessions, 195 placebo sessions and 53 familiarization sessions. The left occipital to vertex signal was quantified using power spectral density analyses. EEG changes under different conditions were compared using the spectral difference index. Less EEG change from baseline was found after placebo in the first session than after placebo in later sessions. Drug effects were defined by comparisons to placebo effects in the same subjects (related samples analyses) and to placebo effects in other subjects in the data base (independent samples analyses). Decisions using the two analyses were in accord for 27 substance doses: 20 were found active, 7 inactive. For one substance, the related samples analysis indicated drug activity, while the independent samples analysis did not (just below criterion). For five other substances, the related samples analyses did not distinguish drug and placebo sessions, while the independent samples analyses showed lesser EEG changes after drug than after placebo. First-session findings support the need for a familiarization session in pharmaco-EEG studies. Placebo findings indicate that past placebo session data are adequate for deciding whether a drug has CNS activity, without the necessity of a placebo session for each subject.

Adult↗